Skip to main content
. 2014 Aug 6;55(8):4853–4862. doi: 10.1167/iovs.14-14353

Figure 5.

Figure 5

Increased labeling of cell death pathway markers after blast. (A–C) Confocal micrographs of RIP1 (green) and RIP3 (red) immunolabeling in control (A), LPS-injected (B), and affected regions of 3- (C) and 28-day (D) postblast retinas. (E–I) Epifluorescence micrographs show caspase-1 immunolabeling (green) in control (E), LPS-injected (F), and affected areas (midperiphery) of 3- (G) and 7- (H) day postblast retinas. The entire retina was positive at 28 days post blast (I). (J, K) Epifluorescence micrographs of caspase-1 (green) and ChAT (red, [J]) or TH (red, [K]) double-labeling, arrows indicate caspase-1 positive nuclei. DAPI-labeled nuclei (blue).